Deepali SawantScientist at Amgen
Deepali Sawant is currently a Principal Scientist at Amgen San Francisco, where she leads a Pharmacology group that delivers preclinical in vivo data to support the oncology pipeline. Prior to joining Amgen in 2017, Deepali conducted postdoctoral studies in the laboratory of Dario Vignali at the University of Pittsburgh and St. Jude Children’s Research Hospital where she worked on elucidating the role of regulatory T cells and inhibitory cytokines in anti-tumor immunity. She received her PhD in Immunology at Indiana University studying transcriptional regulation of regulatory T cell stability in the context of autoimmune and inflammatory diseases. She has authored 20 publications, including 13 first/co-first-author research articles and reviews in high impact peer-reviewed journals.